<DOC>
	<DOCNO>NCT01473758</DOCNO>
	<brief_summary>The purpose trial investigate roflumilast reduce neutrophilic inflammation acute exacerbation Chronic Obstructive Pulmonary Disease ( COPD ) . In addition , potential benefit roflumilast severity recovery period acute COPD exacerbation assess use patient diary questionnaire .</brief_summary>
	<brief_title>Effect Roflumilast Acute Exacerbations Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Participants ask whether agree participate measurement arterial stiffness . Participants agree include substudy , target 60 patient arterial stiffness measurement complete trial . Study terminate due difficulty identify eligible patient exploratory study within reasonable time .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Written inform consent ( IC ) Age â‰¥ 40 year History COPD least 12 month prior enrollment ( Visit V0 ) Chronic productive cough 3 month 2 year prior enrollment ( cause productive cough exclude ) and/or exacerbation predominantly bronchitic symptom enrollment Presentation acute exacerbation COPD associate increased sputum volume change sputum colour Documented fixed airway obstruction determine FEV1/FVC ratio ( postbronchodilator ) &lt; 70 % ( pulmonary function test possible Visit V0 previous measurement take must older 6 month ) Former smoker ( define : smoking cessation least 1 year ago ) current smoker smoke history least 10 pack year Main Diagnosis asthma and/or relevant lung disease Known alpha1antitrypsin deficiency Recurrent exacerbation ( within 8 week precede exacerbation ) Treatment current exacerbation oral corticosteroid and/or antibiotic already start enrollment Treatment PDE4 inhibitor within 3 month prior Visit V0 Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic obstructive pulmonary disease</keyword>
	<keyword>Roflumilast</keyword>
</DOC>